This Moderna Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Considering buying MRNA stock? Here's what analysts think: Moderna Inc has a consensus price target of $143.23 based on the ratings of 25 analysts. The high is $304 issued by Wolfe Research on November 9, 2021. The low is $80 issued by Deutsche Bank on August 6, 2024. The 3 most-recent analyst ratings were released by HS ...